Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01427309Phase 4Completed
A Phase 4 trial of trivalent inactivated influenza vaccine high-dose in influenza, sponsored by Sanofi. Started Sep 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01427309.